Complexes of Niobium(V) and Tantalum(V) Halides
Preparation of MX5(TMU) [M = Nb, X = Cl, 2a; M = Ta, X = F,
2b; M = Ta, X = Cl, 2c]
TaBr5 (1.20 mmol) with tetramethylurea (1.22 mmol). Crystals suit-
able for X-ray analysis were collected by a CH2Cl2 solution layered
with pentane, at room temperature.
General Procedure: Tetramethylurea (0.150 mL, 1.25 mmol) was
added to a suspension of MX5 (1.20 mmol) in CH2Cl2 (10 mL) in
a Schlenk tube. The mixture was stirred for 30 min, during which
progressive dissolution of the solid occurred. The final solution was
layered with pentane (30 mL) and a microcrystalline solid was
formed after 8 h at room temperature.
4: Yellow, C10H24Br10N4O2Ta2 (1393.26): calcd. C 8.6, H 1.7, Cl
57.4, N 4.0, Ta 26.0; found C 8.4, H 1.7, Cl 56.9, N 3.9, Ta 24.5.
Yield: 0.635 g, 76%. 1H NMR (CDCl3): δ = 2.96 (s, 24 H, Me)
ppm. 13C NMR (CDCl3): δ = 170.8 (CO), 39.4 (Me) ppm. IR (solid
state): ν = 2965 (w), 2943 (w), 2799 (vw), 1632 [s (CO)], 1607 (m-
˜
sh), 1515 (s), 1456 (s), 1399 (vs), 1284 (vs), 1210 (vs), 1170 (s), 1146
2a: Orange, C5H12Cl5N2NbO (386.33): calcd. C 15.5, H 3.1, Cl
45.9, N 7.3, Nb 24.1; found C 15.2, H 3.2, Cl 45.4, N 7.6, Nb 23.6.
Yield: 0.389 g, 84%. 1H NMR (CDCl3): δ = 3.29 (s, 12 H, Me)
ppm. 13C NMR (CDCl3): δ = 163.2 (CO), 41.1 (NMe) ppm. IR
(m), 1058 (s), 895 (m), 807 (wm), 783 (vs), 714 (vs) cm–1.
Preparation of MX5(DMF) [M = Nb, X = Cl, 5a; M = Ta, X = F,
5b; M = Ta, X = Cl, 5c (O isomer); M = Ta, X = Cl, 5d (N isomer)]
(solid state): ν = 2946 (wm), 1625 [s (CO)], 1606 (m), 1514 (s), 1461
˜
General
Procedure:
N,N-Dimethylformamide
(0.200 mL,
(ms), 1401 (vs), 1290 (vs), 1222 (ms), 1170 (m), 1058 (s), 894 (m),
2.60 mmol) was added to a Schlenk tube containing a suspension
of MX5 (2.50 mmol) in CH2Cl2 (10 mL). The mixture was stirred
for 20 min, during which progressive dissolution of the solid oc-
curred. The resulting solution was layered with pentane (20 mL),
thus a microcrystalline material was formed after 24–48 h at ambi-
ent temperature. Crystals suitable for X-ray analysis were collected
in the case of 5a and 5c.
784 (vs), 719 (ms) cm–1.
2b: Colorless, C5H12F5N2OTa (392.10): calcd. C 15.3, H 3.1, N 7.1,
Ta 46.2; found C 14.9, H 2.9, N 6.9, Ta 45.7. Yield: 0.362 g, 77%.
1H NMR (CDCl3): δ = 3.01 (s, 12 H, Me) ppm. 13C NMR (CDCl3):
δ = 163.9 (CO), 39.2 (NMe) ppm. 19F NMR (CDCl3): δ = 56.8 (s,
1 F, trans-F), 38.3 (s, 4 F, cis-F) ppm. IR (solid state): ν = 2956
˜
(w), 1626 [s (CO)], 1537 (s), 1474 (ms), 1408 (s), 1321 (m), 1176
5a: Yellow, C3H7Cl5NNbO (343.26): calcd. C 10.5, H 2.1, Cl 51.6,
N 4.1, Nb 27.1; found C 10.2, H 2.3, Cl 50.6, N 3.9, Nb 26.4.
Yield: 0.644 g, 75%. 1H NMR (CDCl3): δ = 8.48 (s, 1 H, CH),
3.43, 3.33 (s, 6 H, NMe) ppm. 13C NMR (CDCl3): δ = 156.7 (CO),
(m), 1062 (m), 900 (m), 808 (m), 734 (wm), 666 (m) cm–1.
2c: Colorless, C5H12Cl5N2OTa (474.37): calcd. C 12.7, H 2.6, Cl
37.4, N 5.9, Ta 38.1; found C 12.4, H 2.4, Cl 38.1, N 6.1, Ta 37.9.
Yield: 0.427 g, 75%. 1H NMR (CDCl3): δ = 2.75 (s, 12 H, Me)
ppm. 13C NMR (CDCl3): δ = 165.3 (CO), 38.4 (NMe) ppm. IR
41.3, 33.5 (NMe) ppm. IR (solid state): ν = 3063 (w), 2968 (w),
˜
2653 (w), 1946 (w), 1651 [vs (CO)], 1472 (m), 1443 (m), 1421 (ms),
1408 (s), 1333 (vs), 1234 (m), 1130 (m), 1052 (m), 976 (wm), 700
(vs) cm–1.
(solid state): ν = 2972 (vw), 2947 (w), 2805 (vw), 1630 [s (CO)],
˜
1516 (s), 1462 (ms), 1402 (vs), 1287 (vs), 1213 (s), 1170 (m), 1142
(m), 1060 (m), 940 (w), 893 (w), 838 (m), 784 (vs), 714 (m) cm–1.
5b: Colorless, C3H7F5NOTa (349.03): calcd. C 10.3, H 2.0, N 4.0,
Ta 51.8; found C 10.0, H 1.6, N 4.3, Ta 51.0. Yield: 0.593 g, 68%.
1H NMR (CDCl3): δ = 8.02 (s, 1 H, CH), 3.01, 2.86 (s, 6 H, NMe)
ppm. 13C NMR (CDCl3): δ = 164.8 (CO), 38.6, 33.5 (NMe) ppm.
19F NMR (CDCl3): δ = 65.9 (br., 1 F, trans-F), 38.8 (br., 4 F, cis-
Preparation of MX5(TEU) [M = Nb, X = Cl, 3a; M = Ta, X = F,
3b; M = Ta, X = Cl, 3c]: These compounds were synthesized by
the same procedure described for 2a–c, by treating MX5
(1.30 mmol) with tetraethylurea (1.35 mmol). Crystals suitable for
X-ray analysis were collected in the case of 3a.
F) ppm. IR (solid state): ν = 2951 (w), 1655 [vs (CO)], 1490 (wm),
˜
1428 (m), 1352 (s), 1246 (m), 1123 (m), 1058 (m), 880 (w), 812 (m),
3a: Red, C9H20Cl5N2NbO (442.44): calcd. C 24.4, H 4.6, Cl 40.1,
789 (m), 690 (s) cm–1.
N 6.3, Nb 21.0; found C 24.2, H 4.9, Cl 38.9, N 6.5, Nb 20.5.
1
Yield: 0.472 g, 82%. H NMR (CDCl3): δ = 3.67 (m, 8 H, CH2),
5c: O-coordinated isomer. Colorless, C3H7Cl5NOTa (431.31):
1.32 (m, 12 H, CH3) ppm. 13C NMR (CDCl3): δ = 168.7 (CO),
calcd. C 8.4, H 1.6, Cl 41.1, N 3.2, Ta 42.0; found C 8.1, H 1.3, Cl
44.6 (CH ), 13.5 (CH ) ppm. IR (solid state): ν = 2979 (m), 2938
˜
1
2
3
39.9, N 3.0, Ta 41.3. Yield: 0.852 g, 79%. H NMR (CDCl3): δ =
(w), 1579 [vs (CO)], 1495 (m), 1483 (m), 1428 (vs), 1383 (s), 1349
(m), 1307 (s), 1276 (vs), 1220 (ms), 1210 (m), 1176 (s), 1148 (m),
1100 (w), 1069 (m), 997 (wm), 971 (s), 841 (w), 788 (w), 729 (vs)
cm–1.
8.57 (s, 1 H, CH), 3.48, 3.36 (s, 6 H, NMe) ppm. 13C NMR
(CDCl3): δ = 167.0 (CO), 40.4, 36.5 (NMe) ppm. IR (solid state):
ν = 1648 [s (CO)] cm–1.
˜
The reaction of TaCl5, suspended in CDCl3 inside a NMR tube
with DMF gave a solution containing 5c and 5d. The 5c/5d ratio
value measured after 5 min was 1:14. Conversion of 5d into 5c was
completed in 72 h.
3b: Colorless, C9H20F5N2OTa (448.21): calcd. C 24.1, H 4.5, N 6.3,
Ta 40.4; found C 23.8, H 4.2, N 6.4, Ta 39.6. Yield: 0.431 g, 74%.
1H NMR (CDCl3): δ = 3.49 (m, 8 H, CH2), 1.28 (m, 12 H, CH3)
ppm. 13C NMR (CDCl3): δ = 162.7 (CO), 43.8 (CH2), 12.7 (CH3)
ppm. 19F NMR (CDCl3): δ = 56.4 (s, 1 F, trans-F), 39.5 (s, 4 F, cis-
F) ppm.
5d: N-coordinated isomer. 1H NMR (CDCl3): δ = 7.80 (s, 1 H,
CH), 2.75, 2.63 (s, 6 H, NMe) ppm. 13C NMR (CDCl3): δ = 162.0
(CO), 36.0, 30.9 (NMe) ppm. IR (solid state): ν = 1660 [s (CO)]
˜
3c: Yellow, C9H20Cl5N2OTa (530.48): calcd. C 20.4, H 3.8, Cl 33.4,
cm–1.
N 5.3, Ta 34.1; found C 19.8, H 3.8, Cl 32.6, N 4.9, Ta 33.5. Yield:
1
3
Preparation of TaCl5(DEF) (6): This compound was synthesized by
the same procedure described for 5a–c, by treating TaCl5
(2.00 mmol) with N,N-diethylformamide (2.20 mmol).
0.552 g, 80%. H NMR (CDCl3): δ = 3.66 (q, JHH = 7.33 Hz, 8
H, CH2), 1.33 (t, JHH = 7.33 Hz, 12 H, CH3) ppm. 13C NMR
3
(CDCl3): δ = 164.8 (CO), 44.6 (CH2), 13.5 (CH3) ppm. IR (solid
state): ν = 2979 (m), 2936 (w), 2873 (vw), 1578 [vs (CO)], 1485 (s),
˜
6: Colorless, C5H11Cl5NOTa (459.36): calcd. C 13.0, H 2.4, Cl 38.6,
1468 (s), 1433 (vs), 1383 (m), 1360 (m), 1308 (vs), 1285 (vs), 1218
(s), 1183 (s), 1148 (m), 1115 (w), 1076 (m), 1055 (wm), 1002 (m),
976 (s), 945 (m), 844 (w), 792 (m), 736 (vs), 717 (s) cm–1.
N 3.0, Ta 39.4; found C 12.8, H 2.4, Cl 37.7, N 2.6, Ta 38.6. Yield:
1
0.735 g, 80%. H NMR (CDCl3): δ = 8.48 (s, 1 H, CH), 3.73 (m,
4 H, NCH2), 1.44 (m, 6 H, NCH2CH3) ppm. 13C NMR (CDCl3):
δ = 165.5 (CO), 47.1, 43.2 (NCH2CH3), 14.0, 12.9 (NCH2CH3)
Preparation of [TaBr4(TMU)2][TaBr6] (4): This compound was syn-
thesized by the same procedure described for 2a–c, by treating
ppm. IR (solid state): ν = 1643 [s (CO)], 1445 (ms), 1352 (m), 1195
˜
Eur. J. Inorg. Chem. 2008, 453–462
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
459